Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial
Abstract Background Alcoholic hepatitis (AH) has the most severe presentation among alcohol-related liver diseases. Corticosteroids are the most widely recommended treatment for severe AH. However, more innovative, refined treatment measures are required because of its high mortality despite cortico...
Main Authors: | Yuri Cho, Youn Su Park, Hwi Young Kim, Won Kim, Heon Ju Lee, Dong Joon Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-018-3092-7 |
Similar Items
-
Comparative Assessment of Validated Prognostic Models in Estimation of 30 Day Mortality in Alcoholic Hepatitis
by: Sree Geetha, et al.
Published: (2018-10-01) -
Granulocyte Colony-Stimulating Factor Receptor mutations in myeloid malignancy
by: Clifford eLiongue, et al.
Published: (2014-05-01) -
Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy
by: Shanshan Chen, et al.
Published: (2021-03-01) -
Development of Site-Specific PEGylated Granulocyte Colony Stimulating Factor With Prolonged Biological Activity
by: Monika Kumari, et al.
Published: (2020-11-01) -
UK Dermatology Clinical Trials Network’s STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial
by: Craig Fiona F, et al.
Published: (2012-04-01)